Feasibility Study of Single-session Solution Focused Consultation to Enhance Treatment Engagement

August 6, 2025 updated by: Nanyang Technological University

Improving Mental Health Treatment Engagement of Patients With Comorbid Chronic Diseases: A Randomized Controlled Evaluation of the Feasibility and Preliminary Effectiveness of a Single-Session Solution-Focused Consultation (SSC) in a Community Setting

This research aims to explore whether a single-session solution-focused consultation (SSC) can increase mental health service engagement among patients with comorbid chronic physical diseases and mental health problems (CPDMHP).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria: 1. A history of one or more chronic physical diseases based on the Ministry of Health (Singapore) Chronic Disease Management Programme guidelines; 2. A score of 5 or more on the Patient Health Questionnaire (PHQ-9) or Generalized Anxiety Disorder-7 (GAD-7); 3. Not currently engaged in formal mental health service; 4. Conversant in the English language; 5. Receiving treatment in a community healthcare setting

Exclusion Criteria: 1. A history of psychosis, intellectual disability, or pervasive developmental disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active Control Group
Single-session supportive therapy based approach
In the supportive consultation session, the interventionist will allow the participant to decide what they wish to discuss during the session and listen empathetically, validate their feelings and offer reassurance to the patient. The exact wording or questions will vary depending on the client's needs and sharing.
Experimental: Intervention Group
Single-session solution-focused therapy based approach
In the SSC, the interventionist first sets expectations, explaining that the session is a means of providing short-term support. The interventionist will then praise the participant for agreeing to receive support and introduce the Action Plan, which will guide the session's structure. The interventionist will then work with the participant to (1) identify a specific, modifiable issue they are facing; (2) use the "miracle question" to envision their ideal outcome where the problem is resolved, and rates their current proximity to that; (3) determine the "smallest possible step" they can take towards this outcome through a scaling exercise; and (4) develop a personalized action plan that leverage on their current resources to begin addressing the problem. Upon ending the SSC, the interventionist writes a personalized note to the participant, highlighting their strengths and expressing confidence in their ability to follow through.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment Engagement - Uptake
Time Frame: Post-intervention (immediate)
Endorsement of interest in referral for mental health services or follow-up session with interventionist
Post-intervention (immediate)
Treatment engagement - Attendance
Time Frame: 2-weeks post-intervention
Attendance at intake session for mental health services or follow-up session with interventionist
2-weeks post-intervention
Feasibility - Intervention Completion Rate
Time Frame: Post-intervention (immediate)
Completion of intervention action plans
Post-intervention (immediate)
Acceptability - Usefulness of intervention
Time Frame: Post-intervention (immediate)
Single item measure on helpfulness of consultation in addressing concern/s
Post-intervention (immediate)
Acceptability - Satisfaction with outcome
Time Frame: Post-intervention (immediate)
Single item measure on how satisfied they are with the intervention's outcome
Post-intervention (immediate)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived agency
Time Frame: From baseline to post-intervention (immediate)
State Hope Scale (SHS) - Pathways Subscale
From baseline to post-intervention (immediate)
Hope
Time Frame: From baseline to post-intervention (immediate) and two-week post intervention
Beck's Hopelessness Scale (BHS-4)
From baseline to post-intervention (immediate) and two-week post intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression
Time Frame: From baseline to two-weeks post intervention
Patient's Health Questionnaire (PHQ-9)
From baseline to two-weeks post intervention
Anxiety
Time Frame: From baseline to two-weeks post intervention
Generalized Anxiety Disorder (GAD-7)
From baseline to two-weeks post intervention
Change readiness
Time Frame: From baseline to post-intervention (immediate) and two-week post intervention
Readiness Ruler
From baseline to post-intervention (immediate) and two-week post intervention
Life satisfaction
Time Frame: From baseline to two-week post intervention
Single-item measuring satisfaction with life
From baseline to two-week post intervention
Perceived current health status
Time Frame: From baseline to two-week post intervention
Single-item measuring perceived current health status
From baseline to two-week post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 26, 2025

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

August 6, 2025

First Submitted That Met QC Criteria

August 6, 2025

First Posted (Actual)

August 11, 2025

Study Record Updates

Last Update Posted (Actual)

August 11, 2025

Last Update Submitted That Met QC Criteria

August 6, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Treatment Engagement

Clinical Trials on Single-session supportive intervention

Subscribe